The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of chemotherapy dose intensity for AYAs on COG AALL1131 versus CALGB 10403.
 
Jennifer Lynn McNeer
No Relationships to Disclose
 
Lingyun Ji
Consulting or Advisory Role - Millennium
 
Xinxin Xu
No Relationships to Disclose
 
Michael Burke
Honoraria - Amgen; Jazz Pharmaceuticals; Shire
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen; Jazz Pharmaceuticals; Shire
Travel, Accommodations, Expenses - Amgen; Jazz Pharmaceuticals; Shire
 
Wanda Salzer
No Relationships to Disclose
 
Meenakshi Devidas
Honoraria - Novartis; PSI
 
Kristina M Laumann
No Relationships to Disclose
 
Charlotte Wood
No Relationships to Disclose
 
Anjali S. Advani
Honoraria - Pfizer
Consulting or Advisory Role - Glycomimetics; Kite, a Gilead company; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Glycomimetics (Inst); KaloBios (Inst); Macrogenics (Inst); Millennium (Inst); Pfizer (Inst); Pfizer (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; Novartis
 
Richard A. Larson
Consulting or Advisory Role - Abbvie; Agios; Amgen; ARIAD; Astellas Pharma; Boston Biomedical; Celgene; Curis; CVS Caremark; DAVA Pharmaceuticals; ERYTECH Pharma; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst); Novartis (Inst); Rafael Pharmaceuticals
Patents, Royalties, Other Intellectual Property - UpToDate
 
Selina M. Luger
Honoraria - Agios; Daiichi Sankyo; Pfizer
Research Funding - ARIAD (Inst); Biosight (Inst); Celgene (Inst); Cyclacel (Inst); Kura Oncology (Inst); Onconova Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Hemedicus; PER
 
Wendy Stock
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Adaptive Biotechnologies; Agios; Amgen; Astellas Pharma; Daiichi Sankyo; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer; SERVIER
Research Funding - Amgen (Inst); Novartis (Inst); Pfizer (Inst); SERVIER (Inst); Sigma-Tau (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Mignon L. Loh
Consulting or Advisory Role - MediSix Therapeutics
 
Stephen Hunger
Stock and Other Ownership Interests - Amgen; Amgen (I); Merck (I); Pfizer (I)
Honoraria - Amgen
Consulting or Advisory Role - Novartis
 
Elizabeth A. Raetz
Research Funding - Pfizer (Inst)
Other Relationship - Celgene; Celgene